ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,226,428, issued on Feb. 18, was assigned to H. Lundbeck A/S (Valby, Denmark).
"Catecholamine prodrugs for use in the treatment of Parkinson's disease" was invented by Klaus Gjervig Jensen (Valby, Denmark), Lisbet Kvaerno (Valby, Denmark), Morten Jorgensen (Valby, Denmark) and Martin Juhl (Valby, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds of formula (I) that are prodrugs of catecholamine for use in treatment of neurodegenerative diseases and disorders. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating neurodegenerative or neuro...